Lorcaserin, Obesity Drug in Development
Mar 9, 2009 @ 04:31 PM — by SEO Admin
New Obesity Drug?
Something which could cause a great deal of excitement is on the horizon in obesity treatment. Arena Pharmaceuticals, a San Diego biotech firm, has an anti-obesity drug in development. The drug, named Lorcaserin, activates specific brain serotonin receptors which suppress appetite, reduce food intake, and produce weight loss. This late-stage developmental drug is still several years away from possible FDA approval. Arena has it on the FDA approval track and has big event scheduled to occur in late March, 2009 when the company will first repo
